Clinical Trial Update: A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating bevacizumab added to capecitabine and cisplatin as first-line therapy for advanced gastric cancer; results from the completed study wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)

Snippet

Sponsor: Genentech, Inc. | Conditions: Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2012-01-19